Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Kobayashi S, Fukushima T, Ueno M, Chuma M, Numata K, Tsuruya K, Arase Y, Hirose S, Kagawa T, Hattori N, Watanabe T, Matsunaga K, Uojima H, Hidaka H, Kusano C, Morimoto M, Maeda S.
Kobayashi S, et al. Among authors: maeda s.
Liver Int. 2024 Jun;44(6):1343-1350. doi: 10.1111/liv.15825. Epub 2024 Mar 4.
Liver Int. 2024.
PMID: 38436529